Your browser doesn't support javascript.
loading
Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients.
Tsai, H J; Chuang, Y W; Lee, S W; Wu, C Y; Yeh, H Z; Lee, T Y.
  • Tsai HJ; Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Chuang YW; Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Lee SW; Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Wu CY; Department of Internal Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Yeh HZ; Division of Translational Medicine, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Lee TY; Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Aliment Pharmacol Ther ; 47(12): 1673-1681, 2018 06.
Article en En | MEDLINE | ID: mdl-29696665

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Crónica / Tenofovir / Guanina Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis B Crónica / Tenofovir / Guanina Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article